Raymond John

Raymond John

Auto-generated profile, based on publicly available information

Raymond John


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2025 in bioRxiv
Verified
Preprint
Open access
AAAdetunji Abdulkabir
Adetunji Abdulkabir
RJRaymond John
Raymond John
ATAliyu Turaki
Aliyu Turaki
TYTajudeen Yahaya
Tajudeen Yahaya
TAThankGod Asekemhe
ThankGod Asekemhe
AKAzeem Kolawole
Azeem Kolawole
Introduction: Previous investigations already established the pharmacological importance of Erythrina senegalensis . The current study was conducted to determine the effect of methanol stem-bark extract of Erythrina senegalensis (MEES) on serum albumin level of carbon tetrachloride (CCl 4 ) induced liver damage in wistar rats. Method: Thirty wister rats of either sex weighing were randomly divided into six groups of five rats each. Group 1 served as the control received standard pelleted rat feed with normal distilled water. Group 2-6 were administered 30% CCl 4 1ml/kg body weight in liquid paraffin at 72hrs interval. Group 2 was untreated while group 3 was orally treated with standard drug salymarin for 14days. Group 4-6 were orally treated respectively with 100, 300 and 500mg/kg body weight of the MEES. Result: The phytochemical analysis of the MEES indicated the presence of saponins, phenols, flavonoids, and tannins while the acute toxicity test showed no adverse reaction within the test population at a dose range of 200–2000mg/kg body weight. Unlike the control, inducement of CCL 4 to Group2-6 indicated significant changes (p < 0.05) in the serum albumin level and hematological parameters. However, treatment with silymarin and increasing doses of the MEES restore the changes. The histopathological studies also reveal that increasing concentration of administered doses of the MEES significantly (p < 0.05) reduces cell necrosis around central vein. Conclusion: The findings reveal that MEES at recommended doses can serve as alternative source for the development of safe, effective, and affordable liver-supplement drug.